Articles
Page 7 of 20
-
Citation: BMC Pharmacology 2009 9(Suppl 2):A65
-
The preventive cardiovascular effect of a combination of statin and angiotensin receptor blocker at sub-therapeutic doses in middle-aged healthy volunteers
Citation: BMC Pharmacology 2009 9(Suppl 2):A63 -
Histamine-neurotrophin-3 interactions in cultured rat astrocytes
Citation: BMC Pharmacology 2009 9(Suppl 2):A61 -
The role of nonneuronal neurotrophins in the brain
Citation: BMC Pharmacology 2009 9(Suppl 2):A59 -
Cellular antioxidant activity of bilirubin in the human endothelial cell line EA.hy 926 is mediated by bilitranslocase
Citation: BMC Pharmacology 2009 9(Suppl 2):A57 -
Cardioprotective effects of bilberry extract on ischemia-reperfusion-induced injury in isolated rat heart
Citation: BMC Pharmacology 2009 9(Suppl 2):A55 -
The role of P2X7 ATP receptors in the nervous system: potential implications in inflammatory and depression-like diseases
Citation: BMC Pharmacology 2009 9(Suppl 2):A53 -
Transactivation within the AT1 angiotensin receptor homodimer: the role of the conserved DRY motif
Citation: BMC Pharmacology 2009 9(Suppl 2):A51 -
The electrophysiological and hemodynamical effects of pyruvate on diabetic and control rat hearts
Citation: BMC Pharmacology 2009 9(Suppl 2):A49 -
Neuromorphological and functional effects of ecstasy during serotonergic damage and recovery
Citation: BMC Pharmacology 2009 9(Suppl 2):A42 -
Bioactivation of nitroglycerin by the East Asian variant of aldehyde dehydrogenase-2
Citation: BMC Pharmacology 2009 9(Suppl 2):A40 -
Active metabolites formed during hepatic first-pass: simulations featuring their contribution to the overall effect in altered liver clearance and drug-drug interactions
Citation: BMC Pharmacology 2009 9(Suppl 2):A38 -
Absolute and relative bioavailabilities of dodeca-2E, 4E, 8E, 10E/Z-tetraenoic acid isobutylamides after intravenous and oral single doses in rats
Citation: BMC Pharmacology 2009 9(Suppl 2):A36 -
Protein kinase C-ζ is involved in the inhibition of eosinophil migration
Citation: BMC Pharmacology 2009 9(Suppl 2):A34 -
A2A adenosine receptor interacting partners (interactome)
Citation: BMC Pharmacology 2009 9(Suppl 2):A32 -
Regulation of CFTR expression and function by NOS isoforms
Citation: BMC Pharmacology 2009 9(Suppl 2):A30 -
Cytokine signalling in human melanoma cells determines susceptability to statin-induced apoptosis
Citation: BMC Pharmacology 2009 9(Suppl 2):A28 -
Attenuation by a novel synthetic analogue of ACTH4-7 of the learning and memory deficits in juvenile rats treated with amphetamine in utero: role of nitric oxide
Citation: BMC Pharmacology 2009 9(Suppl 2):A26 -
From frog oocytes to mammalian cells: substantial differences in modulation of NaV1.4 channel slow kinetic behaviour by the β1 subunit
Citation: BMC Pharmacology 2009 9(Suppl 2):A24 -
3,5-Di-t-butyl catechol (DTCAT) as an activator of the human skeletal muscle ryanodine receptor Ca2+ channel and its evaluation as a test substance for the assessment of susceptibility to malignant hyperthermia
Citation: BMC Pharmacology 2009 9(Suppl 2):A22 -
CaV1.3 L-type calcium channels modulate depression-like behavior in mice independent of deaf phenotype
Citation: BMC Pharmacology 2009 9(Suppl 2):A21 -
L-type voltage-gated calcium channels in hippocampal neurons and their potential as anti-epilept(ogen)ic drug targets
Citation: BMC Pharmacology 2009 9(Suppl 2):A20 -
P2Y1 receptors are linked to KCa2 channels in PC12 cells
Citation: BMC Pharmacology 2009 9(Suppl 2):A18 -
In vitro and in vivo profiling of P-glycoprotein in human neuroblastoma and rhabdomyosarcoma cells under simvastatin exposure
Citation: BMC Pharmacology 2009 9(Suppl 2):A16 -
Characterization of receptors involved in serotonin contractions of isolated human umbilical artery in uncomplicated pregnancy
Citation: BMC Pharmacology 2009 9(Suppl 2):A14 -
Prostaglandin E2 acts via the EP4 receptor to inhibit platelet aggregation
Citation: BMC Pharmacology 2009 9(Suppl 2):A8 -
The targeting of US28 is dependent on GASP-1
Citation: BMC Pharmacology 2009 9(Suppl 2):A1 -
An efficient drug delivery vehicle for botulism countermeasure
Botulinum neurotoxin (BoNT) is the most potent poison known to mankind. Currently no antidote is available to rescue poisoned synapses. An effective medical countermeasure strategy would require developing a d...
Citation: BMC Pharmacology 2009 9:12 -
Evaluation of molecular descriptors for antitumor drugs with respect to noncovalent binding to DNA and antiproliferative activity
Small molecules that bind reversibly to DNA are among the antitumor drugs currently used in chemotherapy. In the pursuit of a more rational approach to cancer chemotherapy based upon these molecules, it is nec...
Citation: BMC Pharmacology 2009 9:11 -
Psychotropic drugs up-regulate the expression of cholesterol transport proteins including ApoE in cultured human CNS- and liver cells
Disturbances in lipid homeostasis and myelination have been proposed in the pathophysiology of schizophrenia and bipolar disorder. We have previously shown that several antipsychotic and antidepressant drugs i...
Citation: BMC Pharmacology 2009 9:10 -
L-arginine supplementation improves aortic vascular relaxation via NO-independent sGC/cGMP signaling in exercised rats
Citation: BMC Pharmacology 2009 9(Suppl 1):P78 -
Sildenafil ameliorates cardiomyopathy in dystrophin-null (mdx) mice
Citation: BMC Pharmacology 2009 9(Suppl 1):P53 -
Acute hemodynamic response to single oral doses of BAY 60-4552, a soluble guanylate cyclase stimulator, in patients with biventricular heart failure
Citation: BMC Pharmacology 2009 9(Suppl 1):P51 -
Nitric oxide-independent vasodilator rescues heme-oxidized soluble guanylate cyclase from proteosomal degradation
Citation: BMC Pharmacology 2009 9(Suppl 1):P49 -
The uremic retention solute p-cresyl sulfate alters NO signal transduction by alteration of the soluble guanylate cyclase redox state
Citation: BMC Pharmacology 2009 9(Suppl 1):P47 -
Effects of carbon monoxide-releasing molecules on cGMP levels and soluble guanylate cyclase activity
Citation: BMC Pharmacology 2009 9(Suppl 1):P45 -
Structural studies of soluble guanylate cyclase
Citation: BMC Pharmacology 2009 9(Suppl 1):P43 -
From biochemical and structural studies of soluble guanylate cyclase toward drug design
Citation: BMC Pharmacology 2009 9(Suppl 1):P39 -
Functional dissection of the cGK substrate IRAG using transgenic models
Citation: BMC Pharmacology 2009 9(Suppl 1):S36 -
cGMP elevation: new treatment options for lower urinary tract disorders
Citation: BMC Pharmacology 2009 9(Suppl 1):S34 -
Role of PKG II in osteoblast mechanotransduction
Citation: BMC Pharmacology 2009 9(Suppl 1):S32 -
Nitrate-induced tolerance, toxicity and preconditioning: a rationale for reconsidering the use of these drugs
Citation: BMC Pharmacology 2009 9(Suppl 1):S30 -
Cyclic GMP-dependent protein kinase regulation of airway smooth muscle in asthma
Citation: BMC Pharmacology 2009 9(Suppl 1):S28 -
cGKI signaling in cardiac hypertrophy
Citation: BMC Pharmacology 2009 9(Suppl 1):S26 -
Lack of correlation between sGC subunit expression and sGC activity in cerebral development is due to non-heterodimerizing subunits in vivo
Citation: BMC Pharmacology 2009 9(Suppl 1):P20 -
Cytidylyl cyclase activity of bacterial exotoxins
Citation: BMC Pharmacology 2009 9(Suppl 1):P16 -
Internalization and degradation of natriuretic peptide receptor-A is stimulated by ligand binding
Citation: BMC Pharmacology 2009 9(Suppl 1):P14 -
ANP mutation causes reduced proteolysis
Citation: BMC Pharmacology 2009 9(Suppl 1):P12 -
In vitro and in vivo studies on the importance of the soluble gyanylyl cyclase alpha 1 subunit in penile erection
Citation: BMC Pharmacology 2009 9(Suppl 1):P10 -
Impaired NO-cGMP signaling in the pathogenesis of neonatal pulmonary hypertension and therapeutic implications
Citation: BMC Pharmacology 2009 9(Suppl 1):S1